Nastech Pharmaceutical Company Inc. Complies with Nasdaq Marketplace Rule 4350(b)(1)(B)

Published: Mar 24, 2008

BOTHELL, Wash.--(BUSINESS WIRE)--Nastech Pharmaceutical Company Inc. (Nasdaq: NSTK), in compliance with Nasdaq Marketplace Rule 4350(b)(1)(B), which requires separate disclosure of receipt of an audit opinion that contains a going concern qualification, disclosed that our Annual Report (Form 10-K) for the year ended December 31, 2007 contains a going concern qualification from our independent registered public accounting firm, KPMG LLP.

Back to news